1-3 of 3
Miroslav Herman
Close
Sort by
Journal Articles

Prognostic Value of the Parameters of Myeloma Bone Disease Signaling in Patients with Newly Diagnosed Multiple Myeloma Treated with Proteasome Inhibitors

Jiri Minarik, MD PhD, Zuzana Hermanova, Jan Hrbek, Pavla Petrova, Patrik Flodr, Petra Krhovska, Tomas Pika, Jaroslav Bacovsky, Miroslav Herman, Vlastimil Scudla
Journal: Blood
Blood (2016) 128 (22): 5603.
https://doi.org/10.1182/blood.V128.22.5603.5603
Published: 2016
Journal Articles

Assessment of the Parameters of Myeloma Bone Disease Signaling to the Extent of Skeletal Involvement, Bone Mineral Turnover and Activity of Multiple Myeloma

Jiri Minarik, Zuzana Hermanova, Pavla Petrova, Jana Zapletalova, Jan Hrbek, Petra Pusciznova, Jaroslav Bacovsky, Tomas Pika, Miroslav Herman, Vlastimil Scudla
Journal: Blood
Blood (2015) 126 (23): 1754.
https://doi.org/10.1182/blood.V126.23.1754.1754
Published: 2015
Journal Articles

The Use Of Selected Parameters Of Bone Microenvironment For The Assessment Of Skeletal Involvement and Activity In Multiple Myeloma and Monoclonal Gammopathy Of Undetermined Significance

Jiri Minarik, MD, PhD, Petra Pusciznova, MD, Pavla Petrova, MD, Miroslav Herman, prof. MD, Ph.D., Tomas Pika, MD, PhD, Jan Hrbek, MD, Jaroslav Bacovsky, MD, Ph.D., Jana Zapletalova, Vlastimil Scudla, Prof. MD, Ph.D.
Journal: Blood
Blood (2013) 122 (21): 5339.
https://doi.org/10.1182/blood.V122.21.5339.5339
Published: 2013